Shikowitz M J
Department of Otolaryngological and Communicative Disorders, Long Island Jewish Medical Center, New Hyde Park, NY 11042.
Laryngoscope. 1992 Mar;102(3):300-10. doi: 10.1288/00005537-199203000-00012.
Papillomavirus infection of the upper aerodigestive tract is a serious and potentially life-threatening disease which can result in complete respiratory obstruction. Papillomas are the most common benign neoplasm of the larynx in children but have been shown to have an equal propensity to occur in adults. The hallmark of this disease is one of multiple recurrences despite adequate surgical removal, often resulting in a frustrating and prolonged clinical course. Multiple treatment modalities have been used throughout the years, unfortunately with limited success. Recent reports on the treatment of virally induced lesions with photodynamic therapy (PDT) using hematoporphyrin derivative (HPD) or its newly purified form dihematoporphyrin ether (DHE) as photosensitizing agents have appeared in the literature. The successful treatment of papillomas in both the animal model and humans holds great promise. The most commonly used activating light source has been the argon pumped-dye laser (ADL) which produces a continuous wave of coherent light at 630 nm. Although the ADL has proved efficacious in most studies, its cost, size, special cooling water requirements, and large electrical power requirements with limited power output have made it a less than desirable clinical tool. The gold vapor laser (GVL) has been recently proposed as a possible alternate light source for PDT. This laser appears to be more efficient and offers greater power output while requiring less electrical energy than the ADL. The GVL does not produce the same continuous wave light as the ADL but emits pulsed light with high peak power pulses. Some reports have shown a greater tumor response using the GVL at 628 nm, possibly because of greater tissue penetration from the high-peak power pulses. At this time, no studies have investigated the effects of pulsed light during PDT on virally induced papillomas. The present study was conducted to evaluate the efficacy of pulsed light from a GVL as compared to continuous wave light of the ADL in the treatment of papillomas with DHE phototherapy. Statistical analysis of the rate of tumor response, histological changes, and molecular analysis of viral DNA from the involved tissues were performed. Results have shown that the GVL did produce a greater initial rate of tumor response during the first 3 weeks after PDT but did not improve the overall cure rate. Histological and molecular analysis of the treated tissues demonstrated that similar results were obtained when either the ADL or GVL were used as activating light sources.
上呼吸道消化道的乳头瘤病毒感染是一种严重且可能危及生命的疾病,可导致完全性呼吸道梗阻。乳头状瘤是儿童喉部最常见的良性肿瘤,但已证明在成人中也有同样的发病倾向。尽管手术切除充分,但这种疾病的特点之一是多次复发,常常导致令人沮丧且漫长的临床病程。多年来人们使用了多种治疗方法,但遗憾的是成效有限。近期文献中出现了关于使用血卟啉衍生物(HPD)或其新提纯形式双血卟啉醚(DHE)作为光敏剂,通过光动力疗法(PDT)治疗病毒诱导性病变的报道。在动物模型和人类中乳头状瘤的成功治疗前景广阔。最常用的激活光源是氩离子泵浦染料激光器(ADL),它能在630纳米处产生连续的相干光。尽管ADL在大多数研究中已证明有效,但其成本、尺寸、特殊的冷却水需求以及功率输出有限却需要大量电力,这使其成为一种不太理想的临床工具。金蒸汽激光器(GVL)最近被提议作为PDT的一种可能替代光源。这种激光器似乎更高效,输出功率更大,且与ADL相比所需电能更少。GVL不像ADL那样产生连续光,而是发射具有高峰值功率脉冲的脉冲光。一些报告显示,在628纳米处使用GVL时肿瘤反应更大,这可能是由于高峰值功率脉冲对组织的穿透性更强。目前,尚无研究调查PDT期间脉冲光对病毒诱导的乳头状瘤的影响。本研究旨在评估与ADL的连续光相比,GVL的脉冲光在DHE光疗治疗乳头状瘤中的疗效。对肿瘤反应率、组织学变化以及受累组织中病毒DNA的分子分析进行了统计分析。结果表明,GVL在PDT后的前3周确实产生了更高的初始肿瘤反应率,但并未提高总体治愈率。对治疗组织的组织学和分子分析表明,使用ADL或GVL作为激活光源时获得了相似的结果。